Literature DB >> 29406006

Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.

Michelle Blanco Lemelman1, Lisa Letourneau2, Siri Atma W Greeley3.   

Abstract

Neonatal diabetes mellitus is likely to be due to an underlying monogenic defect when it occurs at less than 6 months of age. Early recognition and urgent genetic testing are important for predicting the clinical course and raising awareness of possible additional features. Early treatment of sulfonylurea-responsive types of neonatal diabetes may improve neurologic outcomes. It is important to distinguish neonatal diabetes mellitus from other causes of hyperglycemia in newborns. Other causes include infection, stress, inadequate pancreatic insulin production in preterm infants, among others. This review explores the diagnostic approach, mutation types, management, and clinical course of neonatal diabetes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetic; Glyburide; Insulin; Monogenic diabetes; Neonatal diabetes

Mesh:

Substances:

Year:  2017        PMID: 29406006      PMCID: PMC5928785          DOI: 10.1016/j.clp.2017.10.006

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  50 in total

Review 1.  Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth.

Authors:  Ming Liu; Israel Hodish; Leena Haataja; Roberto Lara-Lemus; Gautam Rajpal; Jordan Wright; Peter Arvan
Journal:  Trends Endocrinol Metab       Date:  2010-08-18       Impact factor: 12.015

2.  Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.

Authors:  A S Slingerland; R Nuboer; M Hadders-Algra; A T Hattersley; G J Bruining
Journal:  Diabetologia       Date:  2006-09-19       Impact factor: 10.122

3.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.

Authors:  Anna L Gloyn; Ewan R Pearson; Jennifer F Antcliff; Peter Proks; G Jan Bruining; Annabelle S Slingerland; Neville Howard; Shubha Srinivasan; José M C L Silva; Janne Molnes; Emma L Edghill; Timothy M Frayling; I Karen Temple; Deborah Mackay; Julian P H Shield; Zdenek Sumnik; Adrian van Rhijn; Jerry K H Wales; Penelope Clark; Shaun Gorman; Javier Aisenberg; Sian Ellard; Pål R Njølstad; Frances M Ashcroft; Andrew T Hattersley
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

4.  Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype.

Authors:  S E Flanagan; D J G Mackay; S A W Greeley; T J McDonald; V Mericq; J Hassing; E J Richmond; W R Martin; C Acerini; A M Kaulfers; D P Flynn; J Popovic; M A Sperling; K Hussain; S Ellard; A T Hattersley
Journal:  Diabetologia       Date:  2012-10-31       Impact factor: 10.122

5.  Mutant proinsulin proteins associated with neonatal diabetes are retained in the endoplasmic reticulum and not efficiently secreted.

Authors:  Soo-Young Park; Honggang Ye; Donald F Steiner; Graeme I Bell
Journal:  Biochem Biophys Res Commun       Date:  2009-12-23       Impact factor: 3.575

Review 6.  Genetics and pathophysiology of neonatal diabetes mellitus.

Authors:  Rochelle N Naylor; Siri Atma W Greeley; Graeme I Bell; Louis H Philipson
Journal:  J Diabetes Investig       Date:  2011-06-05       Impact factor: 4.232

7.  The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study.

Authors:  Elisa De Franco; Sarah E Flanagan; Jayne A L Houghton; Hana Lango Allen; Deborah J G Mackay; I Karen Temple; Sian Ellard; Andrew T Hattersley
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

8.  Diabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis.

Authors:  Lisa R Letourneau; David Carmody; Kristen Wroblewski; Anna M Denson; May Sanyoura; Rochelle N Naylor; Louis H Philipson; Siri Atma W Greeley
Journal:  Diabetes Care       Date:  2017-08-04       Impact factor: 19.112

9.  Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes.

Authors:  M N Weedon; A T Hattersley; K A Patel; R A Oram; S E Flanagan; E De Franco; K Colclough; M Shepherd; S Ellard
Journal:  Diabetes       Date:  2016-04-05       Impact factor: 9.461

10.  GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency.

Authors:  Elisa De Franco; Charles Shaw-Smith; Sarah E Flanagan; Maggie H Shepherd; Andrew T Hattersley; Sian Ellard
Journal:  Diabetes       Date:  2012-12-06       Impact factor: 9.461

View more
  27 in total

1.  ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate KATP channels.

Authors:  Jelena Sikimic; Timothy S McMillen; Cita Bleile; Frank Dastvan; Ulrich Quast; Peter Krippeit-Drews; Gisela Drews; Joseph Bryan
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

Review 2.  Cerebral Effects of Neonatal Dysglycemia.

Authors:  Megan E Paulsen; Raghavendra B Rao
Journal:  Clin Perinatol       Date:  2022-04-21       Impact factor: 2.642

3.  Evaluation of clinical efficacy of continuous care with improved insulin injection techniques on patients with diabetes mellitus: a randomized controlled trial.

Authors:  Fang-Ying Zhang; Mengyuan Shen; Li-Qin Sun
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

Review 4.  Overview of Atypical Diabetes.

Authors:  Jaclyn Tamaroff; Marissa Kilberg; Sara E Pinney; Shana McCormack
Journal:  Endocrinol Metab Clin North Am       Date:  2020-10-14       Impact factor: 4.741

5.  Uncommon Presentations of Diabetes: Zebras in the Herd.

Authors:  Karen L Shidler; Lisa R Letourneau; Lucia M Novak
Journal:  Clin Diabetes       Date:  2020-01

6.  Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Sulfonylurea in the Treatment of KCNJ11 Neonatal Diabetes.

Authors:  Morten Hindsø; Christoffer Martinussen; Maria Saur Svane; Simon Veedfald; Birthe Gade-Rasmussen; Torben Hansen; Sten Madsbad
Journal:  Eur J Case Rep Intern Med       Date:  2021-03-31

7.  Case Report: Neonatal Diabetes Mellitus Caused by a Novel GLIS3 Mutation in Twins.

Authors:  Shira London; Elisa De Franco; Ghadir Elias-Assad; Marie Noufi Barhoum; Clari Felszer; Marina Paniakov; Scott A Weiner; Yardena Tenenbaum-Rakover
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-18       Impact factor: 5.555

Review 8.  Genome Editing Human Pluripotent Stem Cells to Model β-Cell Disease and Unmask Novel Genetic Modifiers.

Authors:  Matthew N George; Karla F Leavens; Paul Gadue
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 6.055

9.  Monogenic and syndromic diabetes due to endoplasmic reticulum stress.

Authors:  Stephen I Stone; Damien Abreu; Janet B McGill; Fumihiko Urano
Journal:  J Diabetes Complications       Date:  2020-05-08       Impact factor: 2.852

Review 10.  Precision medicine approaches for diabetic kidney disease: opportunities and challenges.

Authors:  Sok Cin Tye; Petra Denig; Hiddo J L Heerspink
Journal:  Nephrol Dial Transplant       Date:  2021-06-22       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.